School of Medicine
Showing 1-3 of 3 Results
-
Aussama Nassar, MD, MSc,FACS, FRCSC
Clinical Professor, Surgery - General Surgery
BioDr. Nassar is a clinical Professor in surgery, board-certified in both General Surgery and Surgical Critical Care in the United States and Canada, underscoring his exceptional expertise in these fields. He holds a Master of Science in Health Science Education from McMaster University, Canada, further solidifying his strong academic foundation.
Currently, Dr. Nassar serves as the inaugural Director of the Emergency General Surgery Service and the Director of the Surgical Critical Care Fellowship Program at Stanford University. He is also the founder and director of the Surgery Resident Coaching Program. With over 12 years of clinical and academic experience at premier tertiary care referral centers across North America, Dr. Nassar brings unparalleled knowledge and leadership to his roles.
Dr. Nassar's clinical interests include trauma, acute care surgery, critical care, and a particular focus on abdominal wall reconstruction. As a dedicated clinician-educator, he is a certified simulation educator and serves as a course director for ATLS and ASSET programs. His research is centered on advancing surgical education, with an emphasis on fostering the development of non-technical skills in surgical training.
In addition to his educational initiatives, Dr. Nassar is actively engaged in developing innovative assessment tools for surgical trainees and addressing burnout among physicians and healthcare professionals. With a strong national and international presence, Dr. Nassar continues to shape the future of surgical education and healthcare delivery through his leadership, research, and advocacy. -
Pooja U. Neiman, MD, MPA
Assistant Professor of Surgery (General Surgery)
BioPooja Neiman is a Trauma and Acute Care Surgeon and an Assistant Professor of Surgery at the Stanford School of Medicine. She completed her Acute Care and Surgical Critical Care fellowships at UCSF in San Francisco, CA in 2026 and her General Surgery residency at the Brigham and Women's Hospital in Boston, MA in 2024. She was a National Clinician Scholars Program (NCSP) Fellow at the University of Michigan from 2020-2022, where her work focused on the clinical and financial outcomes for surgical patients after health policy changes. During the height of the COVID-19 pandemic, she also volunteered with the Michigan Department of Health and Human Services Testing Team to bring K-12 students in the state safely back to school.
Prior to surgical residency, she completed her medical education at the UCLA David Geffen School of Medicine and received her Master's in Public Administration at the Harvard Kennedy School of Government. While in college, Pooja launched a non-profit called Mobilizing Health, an organization that partnered with physicians and community leaders to deliver medical advice via text message to more than 5,000 patients in rural India. After running Mobilizing Health full-time and overseeing its transition to UNICEF, she focused on issues related to access to health care domestically.
Having grown up in a family that incurred medical debt while uninsured and later gained coverage through the Affordable Care Act, she knows firsthand how much consistent access to care can change a family's life. Pooja believes that access to high-value, affordable health care is a basic need, and that trauma systems, which care for every injured patient regardless of insurance or ability to pay, are a cornerstone of that access. Her research examines how insurance, financial hardship, and the social conditions of patients' lives shape their recovery after injury and emergency surgery, with the goal of informing policies that help patients not only survive but fully recover. -
Jeffrey Norton, MD
Robert L. and Mary Ellenburg Professor of Surgery, Emeritus
Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.